Estimation of the prevalence of Hemoglobinopathies in Erbil governorate, Kurdistan region of Iraq

BACKGROUND: Thalassemia syndromes and structural hemoglobin variants generate blood crisis of variable clinical symptoms, ranging from mild-to-moderate hematological disorder to severe, lifelong, transfusion-dependent anemia. The aim of current study was to uncover the prevalence of thalassemia and...

Full description

Bibliographic Details
Main Authors: Sarkar S Aziz, Bahra K Hamad, Hero O Hamad, Muzhda I Qader, Eman N Ali, Rayan H Muhammed, Mudhir Sabir Shekha
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Iraqi Journal of Hematology
Subjects:
Online Access:http://www.ijhonline.org/article.asp?issn=2072-8069;year=2022;volume=11;issue=1;spage=19;epage=24;aulast=Aziz
_version_ 1811217838141079552
author Sarkar S Aziz
Bahra K Hamad
Hero O Hamad
Muzhda I Qader
Eman N Ali
Rayan H Muhammed
Mudhir Sabir Shekha
author_facet Sarkar S Aziz
Bahra K Hamad
Hero O Hamad
Muzhda I Qader
Eman N Ali
Rayan H Muhammed
Mudhir Sabir Shekha
author_sort Sarkar S Aziz
collection DOAJ
description BACKGROUND: Thalassemia syndromes and structural hemoglobin variants generate blood crisis of variable clinical symptoms, ranging from mild-to-moderate hematological disorder to severe, lifelong, transfusion-dependent anemia. The aim of current study was to uncover the prevalence of thalassemia and other hemoglobinopathies in the Erbil governorate, Kurdistan region of Iraq. MATERIALS AND METHODS: The available data of thalassemia major, thalassemia intermedia, sickle cell disease, sickle cell trait, and HbH and HbE until the end of 2020 were collected retrospectively from Erbil Thalassemia Center in Erbil governorate, Kurdistan region of Iraq and analyzed by using Microsoft Excel (Version 2016). RESULTS: An increase in the prevalence of thalassemia syndromes from 30.8/100,000 in 2015 to 37.3/100,000 individuals in the population in 2020 was revealed. The prevalence of all hemoglobinopathies combined increased from 31.9/100,000 to 42.7/100,000 individuals of the population. Thalassemia major was the predominant condition among the hemoglobinopathies with 758 (78.71%) cases out of 963 cases at the end of 2020. CONCLUSION: This rise might be attributed to a large number of consanguineous marriages, the lack of effective prevention programs, and poor legislation. There is an emergent requirement for a preventive program, entailing identification of carriers, genetic counseling, guidelines to differentiate between other microcytic anemias with thalassemia traits, antenatal diagnosis, public education, and sustained legislation.
first_indexed 2024-04-12T07:01:22Z
format Article
id doaj.art-d23f7d758a514acfa3a2a0f408cd3440
institution Directory Open Access Journal
issn 2072-8069
language English
last_indexed 2024-04-12T07:01:22Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Iraqi Journal of Hematology
spelling doaj.art-d23f7d758a514acfa3a2a0f408cd34402022-12-22T03:43:00ZengWolters Kluwer Medknow PublicationsIraqi Journal of Hematology2072-80692022-01-01111192410.4103/ijh.ijh_42_21Estimation of the prevalence of Hemoglobinopathies in Erbil governorate, Kurdistan region of IraqSarkar S AzizBahra K HamadHero O HamadMuzhda I QaderEman N AliRayan H MuhammedMudhir Sabir ShekhaBACKGROUND: Thalassemia syndromes and structural hemoglobin variants generate blood crisis of variable clinical symptoms, ranging from mild-to-moderate hematological disorder to severe, lifelong, transfusion-dependent anemia. The aim of current study was to uncover the prevalence of thalassemia and other hemoglobinopathies in the Erbil governorate, Kurdistan region of Iraq. MATERIALS AND METHODS: The available data of thalassemia major, thalassemia intermedia, sickle cell disease, sickle cell trait, and HbH and HbE until the end of 2020 were collected retrospectively from Erbil Thalassemia Center in Erbil governorate, Kurdistan region of Iraq and analyzed by using Microsoft Excel (Version 2016). RESULTS: An increase in the prevalence of thalassemia syndromes from 30.8/100,000 in 2015 to 37.3/100,000 individuals in the population in 2020 was revealed. The prevalence of all hemoglobinopathies combined increased from 31.9/100,000 to 42.7/100,000 individuals of the population. Thalassemia major was the predominant condition among the hemoglobinopathies with 758 (78.71%) cases out of 963 cases at the end of 2020. CONCLUSION: This rise might be attributed to a large number of consanguineous marriages, the lack of effective prevention programs, and poor legislation. There is an emergent requirement for a preventive program, entailing identification of carriers, genetic counseling, guidelines to differentiate between other microcytic anemias with thalassemia traits, antenatal diagnosis, public education, and sustained legislation.http://www.ijhonline.org/article.asp?issn=2072-8069;year=2022;volume=11;issue=1;spage=19;epage=24;aulast=Azizerbilhemoglobinhemoglobinopathiesprevalencesickle cell disorderthalassemia
spellingShingle Sarkar S Aziz
Bahra K Hamad
Hero O Hamad
Muzhda I Qader
Eman N Ali
Rayan H Muhammed
Mudhir Sabir Shekha
Estimation of the prevalence of Hemoglobinopathies in Erbil governorate, Kurdistan region of Iraq
Iraqi Journal of Hematology
erbil
hemoglobin
hemoglobinopathies
prevalence
sickle cell disorder
thalassemia
title Estimation of the prevalence of Hemoglobinopathies in Erbil governorate, Kurdistan region of Iraq
title_full Estimation of the prevalence of Hemoglobinopathies in Erbil governorate, Kurdistan region of Iraq
title_fullStr Estimation of the prevalence of Hemoglobinopathies in Erbil governorate, Kurdistan region of Iraq
title_full_unstemmed Estimation of the prevalence of Hemoglobinopathies in Erbil governorate, Kurdistan region of Iraq
title_short Estimation of the prevalence of Hemoglobinopathies in Erbil governorate, Kurdistan region of Iraq
title_sort estimation of the prevalence of hemoglobinopathies in erbil governorate kurdistan region of iraq
topic erbil
hemoglobin
hemoglobinopathies
prevalence
sickle cell disorder
thalassemia
url http://www.ijhonline.org/article.asp?issn=2072-8069;year=2022;volume=11;issue=1;spage=19;epage=24;aulast=Aziz
work_keys_str_mv AT sarkarsaziz estimationoftheprevalenceofhemoglobinopathiesinerbilgovernoratekurdistanregionofiraq
AT bahrakhamad estimationoftheprevalenceofhemoglobinopathiesinerbilgovernoratekurdistanregionofiraq
AT heroohamad estimationoftheprevalenceofhemoglobinopathiesinerbilgovernoratekurdistanregionofiraq
AT muzhdaiqader estimationoftheprevalenceofhemoglobinopathiesinerbilgovernoratekurdistanregionofiraq
AT emannali estimationoftheprevalenceofhemoglobinopathiesinerbilgovernoratekurdistanregionofiraq
AT rayanhmuhammed estimationoftheprevalenceofhemoglobinopathiesinerbilgovernoratekurdistanregionofiraq
AT mudhirsabirshekha estimationoftheprevalenceofhemoglobinopathiesinerbilgovernoratekurdistanregionofiraq